Assessment of a Quantra-guided Transfusion Algorithm in Liver Transplantation

Status: Recruiting
Location: See location...
Intervention Type: Biological
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Liver transplantation carries a substantial risk of bleeding, making precise haemostasis control essential, although assessing coagulation remains challenging. Quantra, a bedside viscoelastic testing device using sonorheometric methods, offers an innovative approach to guiding haemostatic management during surgery. The study aims to determine whether a Quantra-guided transfusion can reduce transfusion and bleeding during liver transplantation when compared to a conventional transfusion approach.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Patients aged 18 years or older

• Patient with ESLD undergoing liver transplantation

• Individuals affiliated with or beneficiaries of a social security scheme

• Free and informed written consent obtained in writing from the patient, or where applicable from the trusted person/family member/close relative

Locations
Other Locations
France
Toulouse University Hospital
RECRUITING
Toulouse
Contact Information
Primary
Guillaume PORTA BONETE, Md
porta-bonete.g@chu-toulouse.fr
561323565
Time Frame
Start Date: 2025-03-08
Estimated Completion Date: 2027-03
Participants
Target number of participants: 56
Treatments
Experimental: Transfusion algorithm based on Quantra®
Patients managed using a transfusion algorithm based on Quantra®.
Active_comparator: Conventional transfusion algorithm
Patients managed using a conventional transfusion algorithm.
Related Therapeutic Areas
Sponsors
Leads: University Hospital, Toulouse

This content was sourced from clinicaltrials.gov